Prasanna K. Dadi

Prasanna K. Dadi

Auto-generated profile, based on publicly available information

Prasanna K. Dadi

Vanderbilt University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
MDMatthew T. Dickerson
Matthew T. Dickerson
PDPrasanna K. Dadi
Prasanna K. Dadi
KZKarolina E. Zaborska
Karolina E. Zaborska
ANArya Y. Nakhe
Arya Y. Nakhe
CSCharles M. Schaub
Charles M. Schaub
DJDavid A Jacobson
David A Jacobson
Gi/o-coupled somatostatin or α2-adrenergic receptor activation stimulated β-cell NKA activity, resulting in islet Ca2+ fluctuations. Furthermore, intra-islet paracrine activation of β-cell Gi/o-GPCRs and NKAs by δ-cell somatostatin secretion slowed Ca2+ oscillations, which decreased insulin secretion. β-cell membrane potential hyperpolarization resulting from Gi/o-GPCR activation was dependent on NKA phosphorylation by Src tyrosine kinases. Whereas, β-cell NKA function was inhibited by cAMP-dependent PKA activity. These data reveal that NKA-mediated β-cell membrane potential hyperpolarization is the primary and conserved mechanism for Gi/o-GPCR control of electrical excitability, Ca2+ handling, and insulin secretion.

1 March 2018 in Molecular Metabolism
Verified
Journal Article
Open access
NVNicholas C. Vierra
Nicholas C. Vierra
MDMatthew T. Dickerson
Matthew T. Dickerson
KJKelli L. Jordan
Kelli L. Jordan
PDPrasanna K. Dadi
Prasanna K. Dadi
KKKetaki A. Katdare
Ketaki A. Katdare
DJDavid A Jacobson
David A Jacobson
Single-cell RNA sequencing studies have revealed that the type-2 diabetes associated two-pore domain K+ (K2P) channel TALK-1 is abundantly expressed in somatostatin-secreting δ-cells. However, a physiological role for TALK-1 in δ-cells remains unknown. We previously determined that in β-cells, K+ flux through endoplasmic reticulum (ER)-localized TALK-1 channels enhances ER Ca2+ leak, modulating Ca2+ handling and insulin secretion. As glucose amplification of islet somatostatin release relies on Ca2+-induced Ca2+ release (CICR) from the δ-cell ER, we investigated whether TALK-1 modulates δ-cell Ca2+ handling and somatostatin secretion. To define the functions of islet δ-cell TALK-1 channels, we generated control and TALK-1 channel-deficient (TALK-1 KO) mice expressing fluorescent reporters specifically in δ- and α-cells to facilitate cell type identification. Using immunofluorescence, patch clamp electrophysiology, Ca2+ imaging, and hormone secretion assays, we assessed how TALK-1 channel activity impacts δ- and α-cell function. TALK-1 channels are expressed in both mouse and human δ-cells, where they modulate glucose-stimulated changes in cytosolic Ca2+ and somatostatin secretion. Measurement of cytosolic Ca2+ levels in response to membrane potential depolarization revealed enhanced CICR in TALK-1 KO δ-cells that could be abolished by depleting ER Ca2+ with sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) inhibitors. Consistent with elevated somatostatin inhibitory tone, we observed significantly reduced glucagon secretion and α-cell Ca2+ oscillations in TALK-1 KO islets, and found that blockade of α-cell somatostatin signaling with a somatostatin receptor 2 (SSTR2) antagonist restored glucagon secretion in TALK-1 KO islets. These data indicate that TALK-1 reduces δ-cell cytosolic Ca2+ elevations and somatostatin release by limiting δ-cell CICR, modulating the intraislet paracrine signaling mechanisms that control glucagon secretion.

8 July 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
SGSarah M. Graff
Sarah M. Graff
SJStephanie R. Johnson
Stephanie R. Johnson
PLPaul J. Leo
Paul J. Leo
PDPrasanna K. Dadi
Prasanna K. Dadi
MDMatthew T. Dickerson
Matthew T. Dickerson
EDEmma L. Duncan
Emma L. Duncan
Maturity-onset diabetes of the young (MODY) is a heterogeneous group of monogenic disorders of impaired pancreatic β cell function. The mechanisms underlying MODY include β cell KATP channel dysfunction (e.g., KCNJ11 [MODY13] or ABCC8 [MODY12] mutations); however, no other β cell channelopathies have been associated with MODY to date. Here, we have identified a nonsynonymous coding variant in KCNK16 (NM_001135105: c.341T>C, p.Leu114Pro) segregating with MODY. KCNK16 is the most abundant and β cell–restricted K + channel transcript, encoding the two-pore-domain K + channel TALK-1. Whole-cell K + currents demonstrated a large gain of function with TALK-1 Leu114Pro compared with TALK-1 WT, due to greater single-channel activity. Glucose-stimulated membrane potential depolarization and Ca 2+ influx were inhibited in mouse islets expressing TALK-1 Leu114Pro with less endoplasmic reticulum Ca 2+ storage. TALK-1 Leu114Pro significantly blunted glucose-stimulated insulin secretion compared with TALK-1 WT in mouse and human islets. These data suggest that KCNK16 is a previously unreported gene for MODY.

1 July 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
MBMonica E. Brown
Monica E. Brown
VMVerda E. Miranda
Verda E. Miranda
SNSimone Nevills
Simone Nevills
RHRuiying Hu
Ruiying Hu
PDPrasanna K. Dadi
Prasanna K. Dadi
GGGuoqiang Gu
Guoqiang Gu
Endocrine islet β cells comprise heterogenous subtypes with different gene expression and function levels. Here we study when/how this heterogeneity is induced and how long each subtype maintains its characteristic properties. We show that islet progenitors with distinct gene expression and DNA methylation patterns produce β-cell subtypes of different secretory function, proliferation rate, and viability in male and female mice. These subtypes have differential gene expression that regulates insulin vesicle production or stimulation-secretion coupling and differential DNA methylation in the putative enhancers of these genes. Maternal obesity, a major diabetes risk factor, reduces the proportion of the β-cell subtype with higher levels of glucose responsiveness. The gene signature that defines mouse β-cell subtypes can reliably divide human cells into two sub-populations, with the one having higher predicted glucose responsiveness reduced in diabetic donors. These results suggest that β-cell subtypes can be derived from islet progenitor subsets modulated by maternal nutrition.

15 August 2021 in Development
Verified
Journal Article
Open access
PDF file
MAMolly K. Altman
Molly K. Altman
CSCharles M. Schaub
Charles M. Schaub
PDPrasanna K. Dadi
Prasanna K. Dadi
MDMatthew T. Dickerson
Matthew T. Dickerson
KZKarolina E. Zaborska
Karolina E. Zaborska
DJDavid A Jacobson
David A Jacobson
The melastatin subfamily of the transient receptor potential channels (TRPM) are regulators of pancreatic β-cell function. TRPM7 is the most abundant islet TRPM channel; however, the role of TRPM7 in β-cell function has not been determined. Here, we used various spatiotemporal transgenic mouse models to investigate how TRPM7 knockout influences pancreatic endocrine development, proliferation and function. Ablation of TRPM7 within pancreatic progenitors reduced pancreatic size, and α-cell and β-cell mass. This resulted in modestly impaired glucose tolerance. However, TRPM7 ablation following endocrine specification or in adult mice did not impact endocrine expansion or glucose tolerance. As TRPM7 regulates cell proliferation, we assessed how TRPM7 influences β-cell hyperplasia under insulin-resistant conditions. β-Cell proliferation induced by high-fat diet was significantly decreased in TRPM7-deficient β-cells. The endocrine roles of TRPM7 may be influenced by cation flux through the channel, and indeed we found that TRPM7 ablation altered β-cell Mg2+ and reduced the magnitude of elevation in β-cell Mg2+ during proliferation. Together, these findings revealed that TRPM7 controls pancreatic development and β-cell proliferation, which is likely due to regulation of Mg2+ homeostasis.

25 February 2026 in Diabetologia
Verified
Journal Article
Open access
PDF file
JDJordyn R. Dobson
Jordyn R. Dobson
PDPrasanna K. Dadi
Prasanna K. Dadi
MDMatthew T. Dickerson
Matthew T. Dickerson
ANArya Y. Nakhe
Arya Y. Nakhe
SBSoma Behera
Soma Behera
DJDavid A Jacobson
David A Jacobson
Aims/hypothesis: The two-pore domain K + channel TWIK1-related alkalinisation-activated K + channel 2 (TALK-2) is encoded by KCNK17 , which is one of the most abundant beta cell K + channel transcripts that also shows high islet expression specificity. Polymorphisms that increase islet KNCK17 expression or result in TALK-2 gain-of-function are associated with a predisposition for developing type 2 diabetes. However, there is a gap in knowledge of the beta cell function(s) of TALK-2. As K + channels typically control beta cell Ca 2+ handling, we aimed to examine the TALK-2 channel control of beta cell Ca 2+ homeostasis and the resulting impact on insulin secretion. Methods: Localisation of TALK-2 was evaluated with immunofluorescent staining as well as TALK-2-GFP construct co-expressed with intracellular markers. TALK-2 function was evaluated by measuring changes in cytoplasmic Ca 2+ (Ca 2+ C ), endoplasmic reticulum Ca 2+ (Ca 2+ ER ), ER membrane potential ( V m ), K + currents and insulin secretion in a TALK-2 inducible cell line and/or primary human beta cells with adenoviral-mediated shRNA knockdown (KD) of TALK-2 or scramble shRNA. Results: TALK-2 protein localised to the plasma membrane and ER membrane, and formed functional channels on the ER membrane. Ca 2+ ER release was accelerated by TALK-2 (slope for TALK-2-expressing cells vs controls: 14.8 ± 0.7 vs 8.9 ± 1.3, respectively, shown as mean ± SE), which reduced Ca 2+ ER storage (ΔCa 2+ ER amplitude: TALK-2-expressing cells reduced by 25 ± 5%) and increased basal relative Ca 2+ C (fold increase by 12 ± 2%). Furthermore, TALK-2 diminished ER membrane hyperpolarisation following Ca 2+ ER release (Accelerated Sensor of Action Potentials [ASAP3 ER ] amplitude decreased by 20 ± 0.8% in TALK-2-expressing cells), suggesting that TALK-2 strengthens the electrical driving force for Ca 2+ ER leak. In human beta cells, TALK-2-KD increased Ca 2+ ER stores by reducing Ca 2+ ER leak (2.30 ± 0.12 vs controls 2.65 ± 0.14). Moreover, TALK-2-KD reduced beta cell Ca 2+ C at euglycaemic conditions (2.88 ± 0.36 vs controls 3.16 ± 0.36) and increased beta cell Ca 2+ C influx in response to hyperglycaemic conditions (4.07 ± 0.55 vs controls 3.45 ± 0.48). Human pseudoislets with beta cell-specific TALK-2-KD displayed reduced basal insulin secretion (0.266 ± 0.065 vs controls 0.432 ± 0.073) and enhanced glucose-stimulated insulin secretion (GSIS; 85.01 ± 13.96 vs controls 42.53 ± 5.52). Conclusions/interpretation: These data support the notion that TALK-2 functions on the human beta cell ER membrane to increase the electrical driving force for beta cell Ca 2+ ER release, reduces glucose-stimulated Ca 2+ influx and limits GSIS. Furthermore, TALK-2-mediated amplification of Ca 2+ ER leak likely enhances basal insulin secretion by increasing Ca 2+ C . Therefore, polymorphisms in KCNK17 that increase TALK-2 activity or expression would be predicted to increase type 2 diabetes risk by blunting beta cell glucose-stimulated Ca 2+ influx, limiting GSIS, promoting Ca 2+ ER leak and elevating basal insulin secretion. Graphical